高润霖-话题@MedSci

#高润霖#

20篇内容 | 649人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1659527, encodeId=765c165952e01, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, objectType=article, longId=193428, objectId=0ecb1934282c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecb1934282c, replyNumber=0, likeNumber=35, createdTime=2021-02-27, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecb1934282c, moduleTitle=J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ecb1934282c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659528, encodeId=9e4816595288b, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, objectType=article, longId=193784, objectId=8b22193e84a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b22193e84a6, replyNumber=0, likeNumber=36, createdTime=2020-11-25, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b22193e84a6, moduleTitle=烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b22193e84a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659526, encodeId=35ff165952612, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=Ame J Cardiol：高润霖院士等十二五课题组报告，我国≥35岁居民房颤患病率0.71%，预计有487万房颤, objectType=article, longId=144449, objectId=12bf1444490f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12bf1444490f, replyNumber=0, likeNumber=37, createdTime=2019-05-11, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12bf1444490f, moduleTitle=Ame J Cardiol：高润霖院士等十二五课题组报告，我国≥35岁居民房颤患病率0.71%，预计有487万房颤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12bf1444490f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659525, encodeId=7f7e165952589, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖院士：高血压患病率城乡差距在缩小, objectType=article, longId=131348, objectId=bd7d131348d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd7d131348d0, replyNumber=0, likeNumber=34, createdTime=2018-12-18, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd7d131348d0, moduleTitle=高润霖院士：高血压患病率城乡差距在缩小, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd7d131348d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659522, encodeId=099c1659522ad, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？, objectType=article, longId=94548, objectId=7aa79454898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa79454898, replyNumber=0, likeNumber=35, createdTime=2017-11-16, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa79454898, moduleTitle=高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa79454898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659524, encodeId=e53e16595249b, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=【CVM 高峰论坛】高润霖院士：心血管病和糖尿病“双重大国”的挑战, objectType=article, longId=105577, objectId=ec1c1055e7c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec1c1055e7c6, replyNumber=0, likeNumber=39, createdTime=2017-08-16, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec1c1055e7c6, moduleTitle=【CVM 高峰论坛】高润霖院士：心血管病和糖尿病“双重大国”的挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec1c1055e7c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659520, encodeId=287516595204b, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖院士荣获TCT终身成就奖，他表示这个奖属于中国, objectType=article, longId=81498, objectId=17c28149832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17c28149832, replyNumber=0, likeNumber=26, createdTime=2017-04-01, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17c28149832, moduleTitle=高润霖院士荣获TCT终身成就奖，他表示这个奖属于中国, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17c28149832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659523, encodeId=8d2e1659523f3, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=Int J Cardiol：高润霖院士牵头的CPACS研究称，我国急性冠心病患者2年时仅60%规范二级预防用药, objectType=article, longId=95514, objectId=3325955142f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3325955142f, replyNumber=0, likeNumber=29, createdTime=2018-03-27, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3325955142f, moduleTitle=Int J Cardiol：高润霖院士牵头的CPACS研究称，我国急性冠心病患者2年时仅60%规范二级预防用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3325955142f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659521, encodeId=8be91659521b9, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖TCT公布ABSORB China两年结果：生物可吸收支架证据进一步积累, objectType=article, longId=81588, objectId=b4d0815880f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4d0815880f, replyNumber=0, likeNumber=45, createdTime=2017-09-21, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4d0815880f, moduleTitle=高润霖TCT公布ABSORB China两年结果：生物可吸收支架证据进一步积累, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4d0815880f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659519, encodeId=3cf11659519fa, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=MedSci专访高润霖院士：发表高质量文章，文章内容本身要有价值, objectType=article, longId=58142, objectId=544558142c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544558142c3, replyNumber=0, likeNumber=29, createdTime=2016-08-12, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544558142c3, moduleTitle=MedSci专访高润霖院士：发表高质量文章，文章内容本身要有价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=544558142c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659518, encodeId=9d961659518ca, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=TCT2015：高润霖院士报告ABSORB China研究, objectType=article, longId=57571, objectId=add45e571e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=add45e571e9, replyNumber=0, likeNumber=44, createdTime=2016-06-12, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=add45e571e9, moduleTitle=TCT2015：高润霖院士报告ABSORB China研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=add45e571e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659517, encodeId=f3bf165951e26, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=EuroPCR 2015：[高润霖院士]阜外介入治疗左主干病变三年死亡率仅4.2%, objectType=article, longId=51657, objectId=9abb5165ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9abb5165ea6, replyNumber=0, likeNumber=31, createdTime=2016-04-08, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9abb5165ea6, moduleTitle=EuroPCR 2015：[高润霖院士]阜外介入治疗左主干病变三年死亡率仅4.2%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9abb5165ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659516, encodeId=483d1659516ce, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖：关于冠脉支架适宜性的讨论, objectType=article, longId=49496, objectId=a8c849496ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c849496ec, replyNumber=0, likeNumber=42, createdTime=2015-12-08, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c849496ec, moduleTitle=高润霖：关于冠脉支架适宜性的讨论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8c849496ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659515, encodeId=8e5116595152d, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=CIT 2014：高润霖谈药物洗脱支架发展未来, objectType=article, longId=32225, objectId=89203222540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89203222540, replyNumber=0, likeNumber=40, createdTime=2014-08-21, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89203222540, moduleTitle=CIT 2014：高润霖谈药物洗脱支架发展未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89203222540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659514, encodeId=c5c3165951448, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖：心血管介入创新从未停止脚步, objectType=article, longId=23402, objectId=7f1c234026b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f1c234026b, replyNumber=0, likeNumber=40, createdTime=2014-01-14, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f1c234026b, moduleTitle=高润霖：心血管介入创新从未停止脚步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f1c234026b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659513, encodeId=440e1659513de, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖院士：我国心血管疾病形势加重, objectType=article, longId=9133, objectId=bf72913360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf72913360, replyNumber=0, likeNumber=38, createdTime=2012-08-25, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf72913360, moduleTitle=高润霖院士：我国心血管疾病形势加重, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf72913360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659509, encodeId=bc53165950993, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=CIT2012即将召开高润霖院士致辞, objectType=article, longId=4227, objectId=59a6422e32, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59a6422e32, replyNumber=0, likeNumber=51, createdTime=2012-09-11, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59a6422e32, moduleTitle=CIT2012即将召开高润霖院士致辞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59a6422e32)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659511, encodeId=246016595113a, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖院士谈CIT大会发展话介入成果, objectType=article, longId=4796, objectId=51cd4e9650, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51cd4e9650, replyNumber=0, likeNumber=39, createdTime=2013-01-06, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51cd4e9650, moduleTitle=高润霖院士谈CIT大会发展话介入成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51cd4e9650)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659512, encodeId=168616595122f, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖：新版脑卒中筛查与防治指导规范介绍, objectType=article, longId=6374, objectId=5ffe63e4c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ffe63e4c4, replyNumber=0, likeNumber=38, createdTime=2012-07-31, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ffe63e4c4, moduleTitle=高润霖：新版脑卒中筛查与防治指导规范介绍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ffe63e4c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1659510, encodeId=d2d4165951024, content=<a href='/topic/show?id=806510246e98' target=_blank style='color:#2F92EE;'>#高润霖#</a>, objectTitle=高润霖：中国经皮心血管介入治疗发展, objectType=article, longId=4451, objectId=3971445119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3971445119, replyNumber=0, likeNumber=31, createdTime=2012-12-06, rootId=0, userName=fengyi820, userId=061a24999434, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3971445119, moduleTitle=高润霖：中国经皮心血管介入治疗发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3971445119)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高润霖

2020-05-29

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

J Cardiovasc Pharmacol Ther：烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究

2021-02-27

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

烟民心梗应用氯吡格雷和他汀获益大！高润霖院士等发表CPACS-3研究

2020-11-25

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

Ame J Cardiol：高润霖院士等十二五课题组报告，我国≥35岁居民房颤患病率0.71%，预计有487万房颤

2019-05-11

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖院士：高血压患病率城乡差距在缩小

2018-12-18

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？

2017-11-16

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

【CVM 高峰论坛】高润霖院士：心血管病和糖尿病“双重大国”的挑战

2017-08-16

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖院士荣获TCT终身成就奖，他表示这个奖属于中国

2017-04-01

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

Int J Cardiol：高润霖院士牵头的CPACS研究称，我国急性冠心病患者2年时仅60%规范二级预防用药

2018-03-27

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖TCT公布ABSORB China两年结果：生物可吸收支架证据进一步积累

2017-09-21

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

MedSci专访高润霖院士：发表高质量文章，文章内容本身要有价值

2016-08-12

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

TCT2015：高润霖院士报告ABSORB China研究

2016-06-12

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

EuroPCR 2015：[高润霖院士]阜外介入治疗左主干病变三年死亡率仅4.2%

2016-04-08

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖：关于冠脉支架适宜性的讨论

2015-12-08

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

CIT 2014：高润霖谈药物洗脱支架发展未来

2014-08-21

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖：心血管介入创新从未停止脚步

2014-01-14

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖院士：我国心血管疾病形势加重

2012-08-25

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

CIT2012即将召开高润霖院士致辞

2012-09-11

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖院士谈CIT大会发展话介入成果

2013-01-06

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖：新版脑卒中筛查与防治指导规范介绍

2012-07-31

fengyi820 (审核中...)

前往app查看评论内容

#高润霖#

高润霖：中国经皮心血管介入治疗发展

2012-12-06

科室
- - 订阅+
  - 更多科室
工具
服务